کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3404876 1223345 2009 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Caffeine for the management of apnea in preterm infants
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری های عفونی
پیش نمایش صفحه اول مقاله
Caffeine for the management of apnea in preterm infants
چکیده انگلیسی

SummaryConsiderable uncertainty persists regarding the efficacy and safety of methylxanthines (caffeine, theophylline – in intravenous form named aminophylline) for the prevention and treatment of infant apnea. To help inform national guideline development in Kenya we undertook structured literature searches to identify current evidence on caffeine therapy for infant apnea. Available evidence shows that caffeine is as effective as intravenous theophylline (aminophylline), but is safer and easier to give and has better therapeutic properties. It is therefore recommended for the treatment of apnea of prematurity. Caffeine is also the preferred drug if clinicians plan to provide apnea prophylaxis. As prematurity is likely to result in more than 1 million deaths a year, mostly in resource-poor settings, greater efforts need to be made to ensure interventions such as caffeine, currently unavailable in countries such as Kenya, are made more widely available.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Health - Volume 1, Issue 2, December 2009, Pages 190–195
نویسندگان
, , ,